12.15.15 Second Annual CURE-UAB Meeting Emphasizes Need For Public Awareness, Research Funding
Dr. Liliana Losada, associate director of scientific programs at SWHR recently attended the Second International Congress on Underactive Bladder(CURE-UAB) in Denver, Colorado.
7.8.15 Congressional Briefing to Explore Biological Sex Differences’ Impact on Medical Research
Women’s health leaders press for female subjects to be included in basic research studies
6.9.15 SWHR Leads Scientific Roundtable on Alzheimer’s Disease
SWHR held its second interdisciplinary roundtable on understanding sex and gender differences in Alzheimer’s disease May 28-29, 2015 at the Hyatt Regency Crystal City in Arlington, Va.
6.5.15 Flibanserin Nears Approval, But Much Work Remains
The Food and Drug Administration (FDA) Advisory Committee has made history for women by recommending approval of Sprout Pharmaceuticals’ twice-rejected female libido drug Flibanserin.
5.12.15 SWHR Joins ‘Spread the Word’ Campaign Focusing on Coronary Artery Disease and Women’s Health
SWHR teamed with HealthyWomen, the National Association of Nurse Practitioners in Women’s Health, and the Coalition of Labor Union Women in partnership with CardioDx on a new patient advocacy campaign, Spread the Word, to empower women to be proactive in discussing their heart health.
4.4.15 Cosmetics and Personal Care Products Safety and Accountability Act
SWHR is proud to support the Personal Care Products Safety Act, introduced today by Senators Dianne Feinstein and Susan Collins.
